Trial record 1 of 1 for:
GEMCAD 2103 TIRANUS
Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS) (TIRANUS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05661188 |
|
Recruitment Status :
Recruiting
First Posted : December 22, 2022
Last Update Posted : September 13, 2023
|
Sponsor:
Grupo Espanol Multidisciplinario del Cancer Digestivo
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Grupo Espanol Multidisciplinario del Cancer Digestivo
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2027 |
| Estimated Study Completion Date : | June 2028 |